Shirley R. Kuhlmann Collegium Pharmaceutical, Inc (COLL) insider trading activity

Shirley R. Kuhlmann is EVP and General Counsel of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 108,137 shares of COLL, which is worth approximately $3.15 Million. The most recent transaction as insider was on Mar 06, 2025, when has been sold 26,067 shares (Common Stock) at a price of $28.5 per share, resulting in proceeds of $742,909. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 108K

9.27% 3M change

34.23% 12M change

Total Value Held $3.15 Million

Shirley R. Kuhlmann Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 06 2025	SELL Open market or private sale	$742,909 $28.5 p/Share	26,067 Reduced 19.42%	108,137 Common Stock
Mar 05 2025	SELL Open market or private sale	$560,600 $28.03 p/Share	20,000 Reduced 12.97%	134,204 Common Stock
Mar 04 2025	SELL Open market or private sale	$1,123,200 $28.08 p/Share	40,000 Reduced 20.6%	154,204 Common Stock
Mar 04 2025	BUY Exercise of conversion of derivative security	$961,200 $24.03 p/Share	40,000 Added 17.08%	194,204 Common Stock
Feb 10 2025	SELL Payment of exercise price or tax liability	$1,067,437 $30.52 p/Share	34,975 Reduced 18.49%	154,204 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	69,995 Added 27.01%	189,179 Common Stock
Jan 10 2025	SELL Open market or private sale	$914,375 $33.25 p/Share	27,500 Reduced 18.75%	119,184 Common Stock
Jan 10 2025	BUY Exercise of conversion of derivative security	$586,850 $21.34 p/Share	27,500 Added 15.79%	146,684 Common Stock
Sep 06 2024	SELL Open market or private sale	$36,598 $37.46 p/Share	977 Reduced 0.81%	119,184 Common Stock
Sep 05 2024	SELL Open market or private sale	$744,127 $38.66 p/Share	19,248 Reduced 13.81%	120,161 Common Stock
Jun 03 2024	SELL Open market or private sale	$822,250 $32.89 p/Share	25,000 Reduced 15.21%	139,409 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$1,070,177 $33.7 p/Share	31,756 Reduced 16.19%	164,409 Common Stock
Feb 12 2024	BUY Grant, award, or other acquisition	-	76,647 Added 28.1%	196,165 Common Stock
Nov 27 2023	SELL Open market or private sale	$659,968 $25.78 p/Share	25,600 Reduced 17.64%	119,518 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	$407,040 $15.9 p/Share	25,600 Added 15.0%	145,118 Common Stock
Jun 26 2023	SELL Open market or private sale	$397,266 $22.09 p/Share	17,984 Reduced 13.08%	119,518 Common Stock
Feb 13 2023	SELL Open market or private sale	$586,279 $26.88 p/Share	21,811 Reduced 13.69%	137,502 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$643,230 $26.75 p/Share	24,046 Reduced 13.11%	159,313 Common Stock
Feb 10 2023	BUY Grant, award, or other acquisition	-	73,864 Added 28.72%	183,359 Common Stock
Sep 15 2022	SELL Open market or private sale	$697,303 $18.07 p/Share	38,589 Reduced 26.06%	109,495 Common Stock
Aug 11 2022	SELL Open market or private sale	$6,003 $20.01 p/Share	300 Reduced 0.2%	148,084 Common Stock
Mar 16 2022	SELL Payment of exercise price or tax liability	$13,939 $18.99 p/Share	734 Reduced 0.49%	148,384 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$197,086 $17.63 p/Share	11,179 Reduced 6.97%	149,118 Common Stock
Feb 10 2022	BUY Grant, award, or other acquisition	-	71,041 Added 30.71%	160,297 Common Stock
Sep 16 2021	SELL Payment of exercise price or tax liability	$14,438 $19.67 p/Share	734 Reduced 0.82%	89,256 Common Stock

SRK

Shirley R. Kuhlmann

EVP and General Counsel

Stoughton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Value

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

Operation

Value

Type

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL

Account